US-based privately held genomics technology company CS Genetics announced on Thursday that it has named Jay Harger, PhD as its new chief operating officer and Mike Stubbington, PhD as its new chief scientific officer.
In the new role, Harger will be responsible for heading the firm's global operations strategy, to include facilities, manufacturing, supply chain, and program management. He originally joined CS as senior vice president of Operations. He has also served at Illumina for more than 15 years and worked in various senior leadership roles, including senior director of Product Management and senior director of Portfolio Management.
In the new role, Stubbington will be responsible for heading the company's global research and development group. He will also work as site head for the company's UK operations based in Cambridge. He originally joined CS as vice president of Research and Development. He has served in companies such as 10x Genomics and at Wellcome Sanger Institute.
Gilead showcases efficacy of twice-yearly lenacapavir for HIV prevention at IAS 2025
Merck announces Phase 3 trials for once-monthly oral HIV prevention pill MK-8527
GSK announces submission of RSV vaccine Arexvy for FDA review
AstraZeneca's Baxdrostat meets all endpoints in pivotal Phase III hypertension trial
IGI and AbbVie enter global licensing agreement for ISB 2001
REGENXBIO reports RGX-202 preclinical results in Duchenne Muscular Dystrophy
MetaVia doses first patient in 48 mg MAD cohort of DA-1726 Phase 1 trial
GenScript Biotech awarded EcoVadis Silver Medal
Zhimeng Biopharma's CB03-154 ALS Phase 2/3 study receives Chinese clinical trial approval
Taiho Oncology and Taiho Pharmaceutical's INQOVI/venetoclax combination sNDA accepted by US FDA
SciBase introduces Nevisense pilot at Florida research university